Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
158
NCT06206811
Phase 1 Study to Investigate OD-07656 in Healthy Adult Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 12, 2024
Completion: Nov 25, 2024
NCT06850727
Safety and Efficacy of OD-07656 and of Subsequent Vedolizumab Therapy in Moderately to Severely Active Ulcerative Colitis
Phase: Phase 2
Start: Jun 2, 2025
Completion: Nov 30, 2026